Jason A. Deck

Array ( [id] => 11296684 [patent_doc_number] => 09504675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-29 [patent_title] => 'Alpha-ketoheterocycles and methods of making and using' [patent_app_type] => utility [patent_app_number] => 13/983369 [patent_app_country] => US [patent_app_date] => 2012-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 64556 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9198894 [patent_doc_number] => 20130338209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'TREATMENT FOR LIPODYSTROPHY' [patent_app_type] => utility [patent_app_number] => 13/978791 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6938 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503196 [patent_doc_number] => 20120302604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'Modulation of Phospholipase D for the Treatment of the Acute and Chronic Effects of Ethanol' [patent_app_type] => utility [patent_app_number] => 13/359350 [patent_app_country] => US [patent_app_date] => 2012-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 5844 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13359350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313663 [patent_doc_number] => 20120190681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'PICOLINAMIDE INHIBITORS OF KINASES' [patent_app_type] => utility [patent_app_number] => 13/354556 [patent_app_country] => US [patent_app_date] => 2012-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30199 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13354556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324472 [patent_doc_number] => 20120196883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'SELECTIVE CALCIUM CHANNEL ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/354156 [patent_app_country] => US [patent_app_date] => 2012-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16140 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13354156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336169 [patent_doc_number] => 20120202878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'METHOD FOR TREATING PSORIASIS' [patent_app_type] => utility [patent_app_number] => 13/351616 [patent_app_country] => US [patent_app_date] => 2012-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7377 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13351616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442371 [patent_doc_number] => 20120258986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'OLEFIN CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/350864 [patent_app_country] => US [patent_app_date] => 2012-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 45242 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13350864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346942 [patent_doc_number] => 20120207858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'BIOCIDE AND BLEACH COMPOSITIONS AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 13/347854 [patent_app_country] => US [patent_app_date] => 2012-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21363 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13347854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9608509 [patent_doc_number] => 08785676 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-07-22 [patent_title] => 'Citrate co-polyesters' [patent_app_type] => utility [patent_app_number] => 13/374704 [patent_app_country] => US [patent_app_date] => 2012-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5830 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13374704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9999931 [patent_doc_number] => 09044002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Method of controlling harmful arthropod, composition, and electrostatic spray device' [patent_app_type] => utility [patent_app_number] => 13/347582 [patent_app_country] => US [patent_app_date] => 2012-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15448 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13347582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10063834 [patent_doc_number] => 09102666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Methods and drug products for treating Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 13/346081 [patent_app_country] => US [patent_app_date] => 2012-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27641 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13346081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301973 [patent_doc_number] => 20120184529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 13/342363 [patent_app_country] => US [patent_app_date] => 2012-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2378 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13342363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18127523 [patent_doc_number] => 11553712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-17 [patent_title] => Glycols as pathogen inactivating agents [patent_app_type] => utility [patent_app_number] => 13/994207 [patent_app_country] => US [patent_app_date] => 2011-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5710 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192128 [patent_doc_number] => 20130331443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'MULTI-ARM POLYMERIC PRODRUG CONJUGATES OF TAXANE-BASED COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/995287 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19362 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16229439 [patent_doc_number] => 10736969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-11 [patent_title] => Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds [patent_app_type] => utility [patent_app_number] => 13/995415 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18047 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9082039 [patent_doc_number] => 20130267569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'Hydroxylated Aminotriazole Derivatives as ALX Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 13/992156 [patent_app_country] => US [patent_app_date] => 2011-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14390 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347942 [patent_doc_number] => 20120208877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'Skin treatment in antiseptic thin film form with silver' [patent_app_type] => utility [patent_app_number] => 13/373875 [patent_app_country] => US [patent_app_date] => 2011-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 735 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13373875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056095 [patent_doc_number] => 20120077783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'MATERIALS AND METHODS FOR TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS' [patent_app_type] => utility [patent_app_number] => 13/298106 [patent_app_country] => US [patent_app_date] => 2011-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11347 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077783.pdf [firstpage_image] =>[orig_patent_app_number] => 13298106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8241034 [patent_doc_number] => 20120149772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'PROCESS FOR THE PREPARATION OF FESOTERODINE OR A SALT THEREOF' [patent_app_type] => utility [patent_app_number] => 13/295224 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2824 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13295224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9483111 [patent_doc_number] => 08729062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => 'Benzyl azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators' [patent_app_type] => utility [patent_app_number] => 13/294460 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7789 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13294460 [rel_patent_id] =>[rel_patent_doc_number] =>)